Breaking News
The current state of education. She has a point.
This is one of the most compelling testimonies as to what's happening in Antarctica ever heard
Mike Rowe was recently interviewed by Moms for America. This is a real eye opener.
What it takes to make a #2 pencil.
Top Tech News
Watch the Jetson Personal Air Vehicle take flight, then order your own
Microneedles extract harmful cells, deliver drugs into chronic wounds
SpaceX Gigabay Will Help Increase Starship Production to Goal of 365 Ships Per Year
Nearly 100% of bacterial infections can now be identified in under 3 hours
World's first long-life sodium-ion power bank launched
3D-Printed Gun Components - Part 1, by M.B.
2 MW Nuclear Fusion Propulsion in Orbit Demo of Components in 2027
FCC Allows SpaceX Starlink Direct to Cellphone Power for 4G/5G Speeds
How Big Tech Plans To Read Your Mind
AI, Nature & Legal Personhood
Cancer Remission Achieved with Low-Cost Drug | Media Blackout
3 patients experienced complete remission after regularly taking fenbendazole.
But the cancer industry seems to hate it because it only costs about $11 per week.
Fenbendazole (FBZ) is a medicine originally designed to treat worms and parasites in animals. Its sister drugs, Mebendazole and Albendazole, have had remarkable success treating similar ailments in humans with few side effects.
The case series highlights the remarkable stories of three cancer patients who achieved miraculous recoveries with fenbendazole after exhausting all conventional therapies.
After analyzing these cases, the abstract concluded, "FBZ appears to be a potentially safe and effective antineoplastic agent that can be repurposed for human use in treating genitourinary malignancies."
Adding to the growing evidence in support of fendendazole's use case against cancer, an Oklahoma man credited his miraculous cancer recovery to the pet med after overcoming terminal small cell lung cancer, defying a less than 1% survival rate and leaving doctors baffled.
This story is truly remarkable. Watch.